ABSTRACT -A two-generation reproduction toxicity study in rats adding extra endpoints to detect endocrine disrupting activity was conducted using lindane by dietary administration at 0, 10, 60, and 300 ppm, for investigation of its utility. The extra endpoints included anogenital distance (AGD), nipple development, sexual maturation (vaginal opening and preputial separation), estrous cycle, spermatogenesis, sex organ weights, and blood hormone concentrations (thyroid and sex hormones). F1 offspring were examined for emotionality (open field test), motor coordination (rotarod test), as well as learning and memory (pole-climbing test). Hepatic drug-metabolizing enzyme activities were also measured. The results revealed general toxicological effects on parental animals, influence on reproductive function, and altered development of offspring; however, they did not demonstrate any distinct changes in the extra endpoints for detection of endocrine disrupting activity. Adult toxicity was observed in both F0 and F1 animals, including suppressed body weight gain and reduced food consumption in both sexes, and deaths of females at 300 ppm. Convulsions and irritability were observed during the perinatal period in pregnant F1 females given 300 ppm. Pathological examination revealed increased liver weights and centrilobular hepatocellular hypertrophy in both sexes and generations at 10 or 60 ppm and above; in addition, increased kidney weights and increased hyaline droplets in the proximal tubule epithelium, and basophilic renal tubules in males were noted at 10 ppm and above. Pituitary weights were decreased in F0 females and in F1 males and females and adrenal weights were increased in F1 males and females at 300 ppm; however, no histological changes were observed, and manifestations suggesting endocrine disrupting activity related to these changes were lacking. Hypertrophy of the thyroid follicular epithelium in F0 females at 300 ppm and in F1 males at 60 and 300 ppm, and decreases in T3 and/or T4 in both sexes and generations at 300 ppm were presumed to be secondary changes associated with the induction of hepatic drug-metabolizing enzymes. Blood hormone analysis revealed no changes in sex hormones attributable to lindane in males or females. Hepatic drug-metabolizing enzyme activities were increased dose-dependently from 10 ppm in both sexes and generations, with the rise in BROD activity being the most prominent. There were also increases in MROD, EROD, T-6β-OH, and T4-UDP-GT activities (BROD >> EROD > MROD, T-6β-OH, T4-UDP-GT). This suggests that while lindane most strongly induces CYP2B, it also upregulates a number of other drug metabolizing enzymes, such as CYP1A, CYP3A, and UDP-GT. As for effects on reproductive function, lack of maternal behavior, including lactation and retrieval behavior, and consequent total litter loss were observed in F1 dams at 300 ppm. There were no effects of lindane on the estrous cycle, spermatogenesis, mating, fertility, pregnancy, or parturition. Neonatal toxicity was observed in both sexes and generations, including suppressed body weight gain at 60 and 300 ppm, and decreased thymus and spleen weights without histological change at 300 ppm. The postnatal survival rate in F2 offspring was decreased due to lack of maternal behavior in dams at 300 ppm. Post-weaning examination of F1 offspring revealed minor body weight-related delays in sexual maturation (vaginal opening and prepu- Vol. 30 Special Issue tial separation) in both sexes at 300 ppm. Behavioral tests in F1 animals revealed no obvious changes in emotionality, motor coordination, or learning and memory. No changes in AGD or nipple development were found in either sex or generation. In conclusion, no distinct changes were found in any of the extra endpoints for detection of endocrine disrupting activity even at doses at which severe toxicity was manifested, including death. The fact that endocrine disrupting activity of lindane is very weak, may explain the lack of relevant adverse effects. Further study of chemicals, which have more definite endocrine disrupting activity, is thus necessary to establish the validity of the test method. On the other hand, effects of lindane on development and reproductive function of the succeeding generation, which were not elucidated in a past standard reproduction toxicity study conducted with 100 ppm as the highest dose, were detected with administration at 300 ppm. This suggests that reproductive and developmental toxicity can be reliably detected by establishing appropriate doses in two-generation reproduction toxicity studies. This work was conducted as part of a project of the Ministry of Environment, though this paper does not contain any opinions of the Ministry.
INTRODUCTION
Two-generation reproduction toxicity studies using rodents, such as rats, have been widely conducted to assess adverse effects of chemicals, including herbicides and pesticides, on reproductive function of living organisms according to guidelines authorized by individual countries and/or by international organizations such as the OECD. These guidelines primarily deal with assessment of effects on mating and fertility; however, it has become evident from progress in toxicology that the sensitivity of these endpoints is not always appropriately high (Takayama et al., 1995) . In this regard, books have appeared like "Our Stolen Future," published by Colborn et al. in 1996 , together with many reports suggesting reproductive disturbances in wild life (Grier, 1982; Hunt and Hunt, 1977; Gibbs et al., 1991; Guillette et al., 1994; Facemire et al., 1995) , decreases in human sperm counts, morphological anomalies in genitalia, and an increasing trend in testicular and prostatic cancers (Carlsen et al., 1992; Chambers and Malone, 1999; Weir et al., 1999; Fleming et al., 1999) , all of which have pointed out the risk of endocrine disruptors as possible causes. Since conventional test methods are not thought to give sufficient consideration to the effects of endocrine disruptors, developed countries have further revised existing guidelines for predicting endocrine disrupting effects of chemicals.
The present research was conducted as part of a project of the Ministry of the Environment to evaluate the validity of revised test guidelines in Japan, USEPA, and OECD for risk assessment of chemicals, including those for agricultural use (MAFF in Japan, 2000; USEPA, 1998; OECD, 2001) . In our present two-generation reproduction toxicity study in rats, the new protocol with added endpoints to detect endocrine disrupting activity was used with lindane, reported to have endocrine disrupting effects on the estrogen system, as a reference chemical.
Lindane is a pesticide registered in 1949 and deregistered in 1972 in Japan. It has been reported as having estrogenic (Raizada et al., 1980) or antiestrogenic activity (U phous e and Williams , 1989; Chadwick et al., 1988; Cooper et al., 1989) . Testicular damage, reduced sperm counts (Dalsenter et al., 1996) , prolongation of the estrous cycle, and delayed vaginal opening (Uphouse and Williams, 1989; Chadwick et al., 1988; Cooper et al., 1989) have also been reported in rats. In addition, there have been descriptions of testicular damage and reduced sperm counts in F1 male rats after administration to lactating dams (Dalsenter et al., 1997) . The present two-generation reproduction toxicity study in rats adding extra endpoints to detect endocrine disrupting activity, including AGD, nipple development, sexual maturation, estrous cycle, spermatogenesis, sex organ weights, and blood hormone concentrations, was performed to assess comparative utility.
MATERIALS AND METHODS

Chemicals and dietary formulations
Lindane (1α, 2α, 3β, 4α, 5α, 6β-hexachlorocyclohexane (gamma-isomer); CAS No. 58-89-9) was provided by Wako Pure Chemical Industries, Ltd. (Tokyo, Japan) as a 99.5% pure colorless crystalline powder. Dose formulations were prepared by mixing
Administration
F0 animals were given diet containing lindane at concentrations of 10, 60, and 300 ppm for 10 weeks, before mating through the mating period until terminal necropsy in males, and through the mating, gestation, and lactation periods until weaning of F1 offspring (Day 21 post partum) in females. F1 animals were treated from weaning on postnatal day (PND) 21 in the same manner as F0 animals. The dose levels were selected based on the results of a 4-week repeated dose toxicity study of rats of the same strain at dietary doses of 0, 50, 100, 200, and 400 ppm (6/sex/group). Suppressed body weight gain and reduced food consumption were observed in males at 400 ppm and in females at 200 ppm and above. Based on these results, the dose of 300 ppm was set as the highest dose, with 60 and 10 ppm for the middle and low doses, respectively, with a common ratio of approximately 5. The control group received the basic diet only. Data for daily intake of lindane are shown in Table 1 .
Observation and examination of parental animals 1. Clinical signs, body weights, and food consumption Animals were observed every day for clinical signs. Body weights and food consumption were measured once weekly for males and females before mating and on Days 0 (day of copulation), 7, 14, and 20 of gestation and on Days 0 (day of parturition), 4, 7, 14, and 21 post partum for mated females.
Estrous cycle
The estrous cycle was examined by collecting vaginal smears every morning for 2 weeks prior to mating and the mean estrous cycle length was calculated for each female. Females that had an estrous cycle length other than 4 to 6 days were judged as having an irregular estrous cycle.
Mating
Males and females were cohabited day and night on a one-to-one basis within the same group (avoiding siblings for F1 animals) for up to 14 days. Vaginal smears were collected every morning and examined microscopically. Copulation was confirmed by finding of vaginal plugs or sperm in vaginal smears, with that day designated as Day 0 of gestation.
Sperm analysis
At terminal sacrifice, the cauda of one epididymis and one testis were removed from each male. A clump of epididymal sperm was suspended in Medium 199 supplemented with 1% BSA and the percentage of motile sperm was determined using an automatic sperm analyzer (HTM-IVOS, Hamilton-Thorne Research). Tissues were homogenized in purified water and the number of epididymal sperm and testicular homogenization-resistant spermatid were also determined for the control and 300 ppm groups. The incidences of abnormal and tailless sperm were also determined by examining smear samples stained with eosin Y.
Observation of parturition and nursing
Dams were allowed to deliver naturally. They were examined for parturition twice daily (9:00 a.m. and 4:00 p.m.) from Day 21 to 25 of gestation, and the day on which parturition was completed by 4 p.m. was designated as Day 0 post partum. Dams were observed for maternal behavior including lactation, nest building, and cannibalism once daily during the lactation period, which was followed by terminal necropsy after weaning of pups. At necropsy, the uterus was removed and examined for the number of implantations. Animals that had no parturition were necropsied 26 days after copulation. Uteri without visible implantation sites were immersed in 10% ammonium sulfide solution to facilitate detection of implantation sites (Salewski, 1964) .
Pathological examinations
Parental animals were necropsied at terminal sacrifice (F0 animals: 16-18 weeks of age; F1 animals: 21-23 weeks of age) and the brain, pituitary, thyroid, thymus, liver, kidney, adrenal, spleen, testis, epididymis (whole and caudal), seminal vesicles (including coagulating glands and contents), prostate (ventral lobe), ovary, and/or uterus were removed and weighed. However, the livers of animals for measurement of hepatic drug-metabolizing enzyme activities were excluded from organ weight measurement and histopathological examination. For females, the estrous cycle stage at necropsy was examined by observation of vaginal smears. Animals that died and dams that suffered total litter loss were necropsied immediately.
Histopathological examination was conducted on hematoxylin-eosin-stained tissue sections of the following organs/tissues of approximately half of the animals in the control and 300 ppm groups: the pituitary, thyroid, adrenal, liver, kidney, testis, epididymis, seminal vesicle, coagulating gland, prostate (ventral lobe), ovary, oviduct, uterus (including the cervix), and/or vagina. When there were any suspicious changes, the corresponding organs/tissues of the other animals were examined. For the epididymis, longitudinal section samples of the head, body, and caudal portion were prepared and examined. In addition, a total of 6 samples of the ovary of F1 animals were prepared from 3 sections, left and right, every 100 µm from around the central area, and the number of primordial follicles and secondary follicles were counted Bucci et al., 1997; Pedersen and Peter, 1968) . Since convulsions were observed in F1 females, the brain, spinal cord, and sciatic nerve were also examined. Because there was a decrease in pituitary weights of F1 females, the pituitary of 10 animals in the control and 300 ppm groups were stained with Azan for histopathological assessment. Further, immunohistochemical staining of the kidney of 4 males in each group and 4 females in the control and 300 ppm groups, respectively, was performed using anti α 2u globulin antibodies (Panapharm Laboratories Co. Ltd.) for both F0 and F1 animals.
Blood hormone analysis
Twelve males in each group were selected for examination of serum concentrations of TSH, T3, T4, LH, FSH, prolactin, testosterone, and dihydrotestosterone (DHT) at terminal sacrifice. Five or six females in each group exhibiting proestrous or metestrous vaginal smears were also selected for hormone analysis of TSH, T3, T4, LH, FSH, prolactin, estradiol-17β, and progesterone. All animals were allowed to stabilize for one hour before collection of blood samples on decapitation without anesthesia at approximately the same time of day (1 p.m.). The collected blood was centrifuged after being left at room temperature for approximately 30 min and the resulting serum was stored at − 80°C until analysis. All parameters were measured by RIA at Daiichi Pure Chemicals Co., Ltd.
Observation and examination of offspring 1. Viability, clinical signs, and body weights Each litter was assessed for the number of pups delivered (live or stillborn), their sexes, and the presence of external anomalies at birth (PND 0). Live pups were observed daily for clinical signs and mortality until PND 21. On PND 4, litter size was adjusted randomly to 8 pups (equal sex ratio, in principle). Litters with less than 8 pups were maintained as is. Body weights were measured individually on PNDs 0, 4, 7, 14, and 21.
Anogenital distance and nipple development
The anogenital distance (AGD) was measured on PND 4 and the ratio of AGD to the cube root of body weight was also calculated (Gallavan et al., 1999) . All pups were examined for the appearance of areolae or nipples on PND 12.
3. Physical development and reflex and sensory functions F1 offspring were observed for pinna unfolding on PND 2 to 4, upper incisor eruption from PND 6, and eye opening from PND 10. F1 offspring were also examined for the surface righting reflex, corneal reflex, startle response, pain response, and midair righting reflex on PND 19.
Sexual maturation
F1 offspring were assessed for the day of vaginal opening in females from PND 27 and preputial separation in males from PND 35. Body weights were measured on the day of occurrence. In addition, males were examined for the day of completion of preputial separation.
Behavioral functions
F1 animals were subjected to the following tests at 4 to 6 weeks of age (10/sex/group). For emotionality (open field test, Dandiya et al., 1969) , latency time, number of sections entered (ambulation), rearing, grooming, defecation, and urination were counted for 3 min using a cylinder shape field (80 Φ× 60 Hcm, 25 sections, Tokiwa Kagaku Kikai Co., Ltd.). For motor coordination (rotarod test, Lynch et al., 1974) , the number of falls and walking behavior during 3 min of walking time on the rotating drum (diameter of 90 mm, 10 rpm) were determined using a rotarod test apparatus (KN-10, Natsume Seisakusho Co., Ltd.). Learning and memory (pole-climbing test, Cook and Weidley, 1957) were assessed with buzzer presentation as the conditioned stimulus for 10 sec followed by an electric shock on the grid floor as the unconditioned stimulus for 10 sec, and a 20 sec interval between trials. Daily sessions of 10 trials were given for 5 consecutive days and the number of conditioned avoidance responses, unconditioned avoidance responses, and no avoidance responses were determined using a pole-climbing test apparatus (Toyo Sangyo Co., Ltd.).
Pathological examination
All offspring, except for F1 offspring selected for post-weaning examination, were necropsied on PND 21. The brain, thymus, spleen, testis, epididymis, ovary, and uterus were weighed for one male and one female in each litter. In addition, the thymus, spleen, and uterus of 9 or 10 each of F1 and F2 offspring in the control and 300 ppm groups were histologically examined, since decreases in the thymus and spleen weights and an increase in relative uterus weights were observed in F1 and F2 offspring of the 300 ppm group.
Measurement of hepatic drug-metabolizing enzyme activities
Hepatic drug-metabolizing enzyme activities were measured in both sexes after 17 weeks of treatment for F0 animals, and after 2, 4, and 17 weeks of treatment for F1 animals. Liver samples were taken from animals (4/sex/group), which were fasted for approximately 21 hr prior to decapitation. After extracting the blood from the removed liver by injecting rapidly cooled 1.15 w/v% KCl on the hepatic vein side, approximately 25 w/v% homogenates were prepared by adding 1.15 w/v% KCl, and after centrifugation at 9000 ×g for 20 min at 4°C, the supernatants were further centrifuged at 105000 ×g for 60 min at 4°C. Microsome suspensions were prepared by suspending precipitates in 10 mM phosphate buffer (pH 7.4) containing 0.1 mM EDTA, frozen with liquid nitrogen, and stored at −80°C until use. Microsomes were measured for cytochrome P450 content (P450) by CO difference spectrum (Omura and Sato, 1964) , 7-methoxyresorufin O-dealkylase activity (MROD), 7-ethoxyresorufin O-dealkylase activity (EROD), and 7-benzyloxyresorufin O-dealkylase activity (BROD) by fluorescence (Nerurkar et al., 1993) , testosterone 6β-hydroxylase activity (T-6β-OH) by HPLC (Arlotto et al., 1991) , and T4-UDP-glucuronosyltransferase activity (T4-UDP-GT) by RI-TLC (McClain et al., 1989) .
Statistical analyses
Data for offspring obtained before weaning were analyzed on the basis of litter mean values. Metrical data were tested for homogeneity of variance by Bartlett's test (Bartlett, 1937) . When the variance was homogeneous, the one-way analysis of variance was performed, and when heterogeneous, the KruskalWallis test was used (Kruskal and Wallis, 1952) . When a significant inter-group difference was found, Dunnett's test (Dunnett, 1955) or the Dunnett-type multiple comparison test (Dunnett, 1964) was employed. For nonparametric data, the Kruskal-Wallis test was first applied, and when a significant intergroup difference was found, the Dunnett-type multiple comparison test was used. For histopathological findings, analysis was by an a×b chi-square test; when a significant difference was observed, Armitage's chisquare test (Armitage, 1971 ) was used to compare the control and treated groups. The remaining numerical data were analyzed with Fisher's exact probability test (Fisher, 1955) . The level of significance was set at 5% for all analyses. No statistical analysis was performed for clinical signs or necropsy findings.
RESULTS
Effects on parental animals 1. Clinical signs, body weights, and food consumption In clinical signs, no changes attributable to lindane were observed in F0 or F1 males. One F0 male in the 300 ppm group was necropsied after becoming moribund on Day 80 of administration. Despite being diagnosed with myelocytic leukemia based on the results of pathological examination, the death was judged to be incidental because of the single occurrence. Two F0 females died on Day 8 of administration and Day 11 of gestation (Day 84), and two F1 females died on Days 35 and 46 of administration (PNDs 56 and 67), respectively, in the 300 ppm group. In addition, convulsions were observed in two F1 dams, on Days 18 and 20 of gestation at this dose, and four F1 dams showed irritability from the day of parturition to Day 2 post partum (data not shown). Suppressed body weight gain was also observed in both sexes of F0 and F1 animals in the 300 ppm group, with significant differences throughout almost the entire treatment period, together with significantly reduced food consumption in the early and/or middle stages of the pre-mating period and during the gestation and lactation periods (Figs. 1 and 2).
Organ weights
In F0 males, increases in liver and kidney weights were observed in all treated groups, with significant differences in absolute liver weights in the 300 ppm group, relative liver weights in all treated groups, and in absolute and relative kidney weights at 60 and 300 ppm. In F0 females, there was an increase in liver weights in the groups receiving 60 and 300 ppm and a decrease in pituitary weights in the 300 ppm group, with significant differences in both absolute and relative values. In F1 males, dose-dependent increase in kidney weights was observed, with significant differences in absolute and relative weights at 60 and 300 ppm. Liver and adrenal weights tended to be high in F1 males of the 300 ppm group, with significant differences in relative weights. Further, the absolute weights of the pituitaries in F1 males and females of the 300 ppm group were significantly reduced, together with the relative weights in females. In addition, liver weights were elevated in F1 females at 60 and 300 ppm, and adrenal weights in the 300 ppm group tended to be high, with significant differences in relative weights. While relative brain weights were significantly increased in F1 males and females in the 300 ppm group, absolute weights were almost identical to those of the control group, so that this change was thought to be purely a reflection of low body weights at necropsy (Table 2) .
Necropsy findings
Changes attributable to lindane were observed in the livers of both sexes and in the kidneys of males receiving 60 and 300 ppm, consisting of enlargement, prominent lobulated pattern, and/or dark brownish change of the liver, and discoloration and enlargement of the kidney. Necropsy of females that died in the 300 ppm group revealed congestion and edema of the lung, which appear to be related to death, in two F0 females and one F1 female. Besides, enlargement of the spleen and liver were the main findings observed in one F0 male in the 300 ppm group, which was necropsied while moribund. At necropsy of F0 and F1 dams that Vol. 30 Special Issue lost all of their offspring in the 60 and 300 ppm groups, there were no findings that appeared to be explanatory (Table 3) .
Histological findings
Changes attributable to lindane were observed in the livers and thyroids of males and females and in the kidneys of males. In the liver, centrilobular hypertro- Significantly different from the control value at 300 ppm: *, p<0.05; **, p<0.01.
phy of hepatocytes was observed in F0 males and females receiving 60 and 300 ppm, in F1 males of all treated groups, and in F1 females at 60 and 300 ppm. In the kidney, although basophilic renal tubules and hyaline droplets in the proximal tubule epithelium were observed in F0 and F1 males in each group, including the control group, the numbers and incidence were increased significantly by the treatment. There were no obvious differences in the extent of the changes or the conditions manifested between F0 and F1 animals. Although relatively small hyaline droplets were positive for anti-α 2U globulin antibodies, they tended not to react with the antibodies as they increased in size. In the thyroid, hypertrophy of the follicular epithelium was significant in F0 females in the 300 ppm group, and was also observed in one and five F1 males in the 60 ppm and 300 ppm groups, respectively, with significance in the latter case. Since this was observed in only one to three F1 females in each group, including the control group, its relation to lindane was unclear. Examination of pituitaries, with decreased weights, using azan staining demonstrated no significant changes in the 300 ppm group. No histological changes were detected in the adrenals, with increased weights in F1 animals. Moreover, there were no abnormalities in the brains, spinal cords, or sciatic nerves of F1 females.
In dead animals, congestion and edema of the lung that appeared to be related to death were observed in two F0 females in the 300 ppm group. In addition, splenic atrophy, erosion of the glandular stomach, and hypertrophy of the adrenal cortex zona fasciculata cells were observed, suggesting hyposthenia. Pulmonary congestion and edema were further noted in the two F1 females that died in the 300 ppm group, including one for which no abnormalities were found at necropsy. Besides, one F0 male that was necropsied while moribund in the 300 ppm had myelocytic leukemia.
The number of primordial and secondary follicles of the ovaries and the total number of ovarian follicles were examined in F1 females but there were no significant differences between the control and 300 ppm groups (Table 3) .
Blood hormone analysis
As for the thyroid hormones, T3 and/or T4 were decreased significantly or showed a tendency for decrease in both sexes of F0 and F1 animals in the 300 ppm group. On the other hand, no changes attributable to lindane were observed in any of the sex hormones in either sex of F0 or F1 animals. In F1 males, LH demonstrated significantly low or high values in all treated groups; however, the changes were judged not to be toxicologically significant, since dose-dependence was not observed and the differences were slight compared with the control group. Furthermore, although LH was significantly elevated in all treated groups of F1 females, the change was also judged not to be toxicologically significant, since the values were essentially the same as in the control group of F0 females and there were no changes that appeared to be related among the other items examined (Table 4) .
Effects on reproductive function 1. Estrous cycle and sperm analysis
No changes attributable to lindane were observed in the estrous cycling of F0 or F1 females. There was a significant difference in the mean estrous cycle length of F1 females in the 300 ppm group; however, since all the animals in the group exhibited a 4-day cycle, which is normal for rats, it was not considered to be toxicologically significant.
On sperm analysis, no changes caused by lindane were seen in any parameters in F0 or F1 males. The percentages of motile sperm and the sperm counts in F0 males in the 300 ppm group were slightly low, while the incidence of morphologically abnormal sperm was slightly high. However, these changes reflected values for one unmated male in this group, which had no motile sperm, a marked decrease in sperm counts, and an increase in morphologically abnormal sperm. The values for the other F0 males in the 300 ppm group were almost the same as in the control group (Table 5) .
Reproductive performance
No effects attributable to lindane were observed in mating or fertility in F0 or F1 animals. Almost all the mating pairs in each group of F0 and F1 animals copulated and conceived during the initial estrous stage after the initiation of mating, and there were no significant differences in the number of days until copulation, the number of estrous stages without copulation, mating index, or fertility index between the control and treated groups (Table 6 ).
Parturition and nursing
Observation of parturition revealed that most of the F0 and F1 dams in each group delivered normally on Day 21 to 23 of gestation, with no changes attributable to lindane in gestation length, number of implantations, birth index, or gestation index. Dystocia was observed in one F1 dam in the 60 ppm group and the number of implantations in F1 dams in the 10 ppm group was significantly increased. However, these were judged to be incidental changes due to the lack of correlation with the dose.
Regarding nursing, no changes attributable to lindane were seen in F0 dams. On the other hand, total litter loss was observed in six F1 dams in the 300 ppm group by Day 7 post partum. These dams lacked maternal behavior, including lactation or retrieving behavior, and nearly all the offspring died by Day 4 post partum. Further, some of the dams in the 300 ppm group, including those which lost all of their offspring, demonstrated irritability. Lack of retrieving behavior and consequent total litter loss was also observed in one F0 dam in the 300 ppm group; however, this was the only case. Total litter loss was also observed in one F1 dam in the 60 ppm group but this was judged to be unrelated to lindane because the dam exhibited dystocia as an incidental change (Table 6 ). 11.1 ± 2.0 11.3 ± 2.0 11.4 ± 1.2 12.7 ± 3.9 FSH (ng/mL) 12.3 ± 13.9 12.3 ± 11.9 11.8 ± 14.0 12.8 ± 14.7 PRL (ng/mL) 4.85 ± 2.60 4.32 ± 2.18 4.23 ± 2.03 3.57 ± 1.95 T (ng/mL) 176 ± 96.4 170 ± 105.6 109 ± 46.6 142 ± 65.7 DHT (pg/mL) Females Proestrus 6 4 6 6 No. of animals examined 2.14 ± 0.93 1.55 ± 0.05 1.77 ± 0.15 2.15 ± 1.31 LH (ng/mL) 8.0 ± 1.9 7.3 ± 1.4 7.0 ± 0.8 7.8 ± 1.9 FSH (ng/mL) 12.8 ± 13.2 4.0 ± 1.0 8.5 ± 9.5 21.1 ± 17.0 PRL (ng/mL) 26.0 ± 9.3 17.8 ± 5.6 32.2 ± 10.9 23.2 ± 6.7 E2 (pg/mL) 829 ± 264 492 ± 369 524 ± 418 356 ± 237 P (ng/mL) Metestrus or diestrus 6 7 6 6 No. of animals examined 1.98 ± 0.18 2.09 ± 0.29 1.97 ± 0.42 1.80 ± 0.24 LH (ng/mL) 7.1 ± 0.8 7.6 ± 0.8 7.9 ± 1.5 7.5 ± 0.8 FSH (ng/mL) 2.6 ± 1.7 3.9 ± 2.5 4.0 ± 4.3 3.3 ± 3.5 PRL (ng/mL) ND ND ND ND E2 (pg/mL) 1341 ± 426 831 ± 329 673 ± 455 772 ± 522 P (ng/mL) a : Mean ± SD. ND: Not detected (<5 pg/mL). Significantly different from the control value: *, p<0.05; **, p<0.01.
Effects on offspring 1. Viability and clinical signs
In F1 offspring, there were no effects of lindane on the number of offspring born, the number of live offspring, the sex ratio, or the viability. In F2 offspring, on the other hand, although there were no changes in the number of offspring or viability at birth, there were multiple postnatal deaths in the 300 ppm group, leading to significant decreases in the number of live offspring and viability on PND 4. The number of live off- 11.2 ± 1.5 11.9 ± 2.2 12.0 ± 1.8 11.1 ± 1.5 FSH (ng/mL) 4.5 ± 2.3 4.9 ± 1.9 3.9 ± 1.8 5.8 ± 3.5 PRL (ng/mL) 3.02 ± 1.32 2.82 ± 1.73 2.72 ± 1.28 3.43 ± 2.32 T (ng/mL) 137 ± 66 135 ± 71 150 ± 75 164 ± 99 DHT (pg/mL) Females Proestrus 4 6 6 6 No. of animals examined 2.27 ± 0.20 ** 2.12 ± 0.29 ** 1.94 ± 0.28 * 1.58 ± 0.14 LH (ng/mL) 7.0 ± 1.1 7.5 ± 0.9 6.3 ± 1.1 6.1 ± 0.6 FSH (ng/mL) 4.5 ± 0.7 7.6 ± 7.5 18.5 ± 35.3 6.3 ± 6.2 PRL (ng/mL) 24.8 ± 8.7 16.0 ± 5.7 18.0 ± 4.3 17.6 ± 2.9 E2 (pg/mL) 475 ± 129 365 ± 69 796 ± 425 447 ± 222 P (ng/mL) Metestrus or diestrus 5 6 6 6 No. of animals examined 2.76 ± 0.50 2.66 ± 0.49 2.39 ± 0.34 2.52 ± 0.58 LH (ng/mL) 7.1 ± 0.8 6.8 ± 0.1 7.8 ± 1.8 7.2 ± 1.3 FSH (ng/mL) 2.7 ± 0.8 6.5 ± 4.5 3.7 ± 1.3 4.3 ± 2.8 PRL (ng/mL) ND ND ND ND E2 (pg/mL) 1259 ± 407 865 ± 390 701 ± 131 1116 ± 550 P (ng/mL) a : Mean ± SD. ND: Not detected (<5 pg/mL). Significantly different from the control value: *, p<0.05; **, p<0.01. spring at birth was significantly high in the 10 ppm group, and the sex ratio in the 60 ppm was significantly low; however, these were judged to be incidental changes because of no dose-dependence. No changes in clinical signs attributable to lindane were observed in F1 or F2 offspring before weaning. In F2 offspring, there were multiple deaths and lack of suckling in the 300 ppm group up to postnatal Day 4. However, the majority of the cases were associated with abnormalities in nursing behavior of the dams (Table 6 ).
Body weights
Low birth weights and suppressed postnatal body weight gain were noted in both sexes of F1 and F2 offspring in the 300 ppm group. In the 60 ppm group, body weight gain was slightly low in both sexes, with sporadic significant differences in body weights and body weight gain (Fig.2 and Table 6 ).
Anogenital distance and nipple development
No changes attributable to lindane were detected in the AGD of either sex in F1 or F2 offspring. Although the ratio of AGD to the cube root of body weight was significantly low in F1 female offspring in the 10 ppm group, it was judged to be incidental because of the lack of any dose-dependence. Observation of nipple development revealed no abnormalities in either sex of F1 or F2 offspring in any of the treated groups (Table 7) . 13.6 ± 1.4 14.9 ± 1.8 14.5 ± 2.2 13.9 ± 2.4 No. of implantation sites 12.7 ± 1.4 13.8 ± 2.0 13.5 ± 2.1 13.0 ± 2.1 Total no. of offspring at birth 12.4 ± 1.3 13.7 ± 2.0 13.5 ± 2.1 12. 98.51 ± 4.34 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 Day 4-21 Body weight of offspring (g) 6.0 ± 0.4 ** 6.3 ± 0.5 6.4 ± 0.4 6.5 ± 0.5 Day 0 Males 8.9 ± 0.8 ** 9.8 ± 0.9 10.5 ± 1.3 10.3 ± 1.0 Day 4 47.7 ± 3.4 ** 56.9 ± 3.5 59.7 ± 3.6 58.8 ± 4.2 Day 21
5.6 ± 0.3 ** 5.9 ± 0.5 6.0 ± 0.4 6.1 ± 0.4 Day 0 Females 8.6 ± 0.6 ** 9.4 ± 0.9 9.9 ± 1.2 9.8 ± 1.0 Day 4 46.9 ± 3.4 ** 54.8 ± 3.2 57.3 ± 3.4 55.9 ± 3.6 Day 21 F1 adults / F2 offspring 16 21 22 22 No. of pairs 3.2 ± 2.9 2.5 ± 1.2 2.8 ± 1.4 2.5 ± 1. 14.4 ± 3.0 15.3 ± 1.4 16.0 ± 1.9 ** 13.7 ± 2.6 No. of implantation sites 13.4 ± 2.8 14.5 ± 1.7 14.8 ± 1.8 13.2 ± 2.7 Total no. of offspring at birth 13.1 ± 2.8 13.7 ± 3.5 14.7 ± 1.8 * 12.8 ± 2. 90.91 ± 30.15 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 Day 4-21 Body weight of offspring (g) 5.9 ± 0.5 ** 6.4 ± 0.7 6.7 ± 0.5 6.7 ± 0.4 Day 0 Males 7.7 ± 1.2 ** 9.8 ± 1.4 10.3 ± 0.9 10.8 ± 1.0 Day 4 47.5 ± 2.5 ** 57.6 ± 5.8 60.8 ± 3.5 60.2 ± 3.6 Day 21
5.6 ± 0.5 ** 6.0 ± 0.7 6.3 ± 0.5 6.4 ± 0.4 Day 0 Females 7.7 ± 1.1 ** 9.2 ± 1.4 * 9.8 ± 1.0 10.2 ± 1.1 Day 4 46.9 ± 5.3 ** 54.0 ± 6.1 57.9 ± 4.3 57.3 ± 3.4 Day 21 a : Mean ± SD. b : Mating index (%) = Number of animals copulated / number of animals used for mating ×100. c : Fertility index (%) = Number of pregnant females / number of copulated females ×100. d : Gestation index (%) = Number of females delivered live pups / number of pregnant females ×100. e : Birth index (%) = Number of pups born alive / number of implantations ×100. # : One dam did not deliver. $ : One dam died on Day 11 of gestation. & : One unmated female copulated and conceived by cohabiting with a proven male. Significantly different from the control value: *, p<0.05; **, p<0.01.
Physical development and reflex and sensory functions
F1 offspring did not reveal any changes attributable to lindane in pinna unfolding, upper incisor eruption, or eye opening. Although the incidence of pinna unfolding was significantly low on PND 3 in males in the 60 ppm group, this was judged to be incidental because it was not found at the highest dose. In addition, no effects on reflex and sensory function, including surface righting reflex, corneal reflex, startle response, pain response, or midair righting reflex were observed (data not shown) ( Table 8 ).
Sexual maturation
F1 offspring exhibited a significant delay regarding the days on which preputial separation occurred and was completed in males in the 300 ppm group, as well as the day on which vaginal opening occurred in females. There were no significant differences in either the male or female body weights on the days on which sexual maturation was discovered or completed (Table 8) .
Behavioral functions
In the open field test of F1 animals, tendencies for decrease in latency time and increase in ambulation were observed in both sexes in the treated groups; however, no significant differences were detected compared with the control group. Furthermore, no significant differences were evident for rearing, grooming, defecation, or urination. In the rotarod test and poleclimbing test, there were no effects suggesting dysfunction of motor coordination or learning and memory caused by lindane (Table 9 ).
Organ weights
In the 300 ppm group, the absolute weights of the thymus and spleen were significantly low in both sexes in F1 and F2 offspring, with significantly low values or tendencies for decrease in the relative weights. In addition, significant differences were seen in the brain, testis, epididymis, ovary, and uterus in the 300 ppm group. However, these were assumed to be a reflection of suppressed body weight gain observed in this group. In F1 females, the absolute and relative spleen weights Table 7 . Anogenital distance and nipple development in F1/F2 offspring. in the 10 ppm group exhibited significant elevation, as did the relative spleen weights in the 60 ppm group. However, there was no dose-dependence (Table 10 ).
Necropsy and histological findings
In F1 and F2 offspring, dilatation of the renal pelvis, dark-reddish change of the liver, hepatodiaphragmatic nodules, and thymic remnant in the neck were observed in each group; however, there was no correlation with the dose regarding incidences, nor other changes attributable to lindane. In addition, histopathological examination of the thymus and spleen of F1 and F2 offspring, and the uterus of F1 offspring did not reveal any treatment-related changes.
Hepatic drug-metabolizing enzyme activities
Hepatic drug-metabolizing enzyme activities were increased dose-dependently, with similar tendencies for both sexes and generations. Microsomal protein levels and cytochrome P450 contents in the 300 ppm group were 1.1-1.6 fold the control group value. BROD demonstrated the most prominent increase by Table 8 . Physical development and sexual maturation of F1 offspring. 97.7 ± 6.9 88.9 ± 27.5 96.9 ± 8.9 100.0 ± 0.0 Day 3 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 Day 4 Incisor eruption Males 10.4 ± 0.8 10.8 ± 0.8 10.5 ± 1.0 10.5 ± 1.1 Age (day) b Females 10.2 ± 0.8 10.7 ± 1.0 10.3 ± 0.9 10.5 ± 0.9 Age (day) Eye opening Males 14.0 ± 0.5 14.1 ± 0.7 13.8 ± 0.4 14.0 ± 0.4 Age (day) Females 13.9 ± 0.5 13.6 ± 0.6 13.6 ± 0.5 13.8 ± 0.4 Age (day)
Sexual maturation
Preputial separation (male) 41.6 ± 1.5 ** 40.0 ± 1.2 39.7 ± 1.2 40.1 ± 1.4 Start (day) 191.9 ± 21.5 200.7 ± 19.3 202.4 ± 13.8 202.9 ± 16.5 Body weight (g) c 44.3 ± 2.1 ** 42.3 ± 1.3 42.7 ± 1.6 42.4 ± 1.8 End (day) 215.6 ± 29.0 221.7 ± 19.9 226.5 ± 16.0 223.7 ± 22.1 Body weight (g) Vaginal opening (female) 33.9 ± 1.9 * 32.5 ± 1.9 32.0 ± 1.6 32.5 ± 1.3 Age (day) 109.9 ± 13.2 116.8 ± 12.9 117.2 ± 11.3 116.4 ± 9.4 Body weight (g) a : Mean ± SD. b : Day of completion. c : Body weight on the completion day. Significantly different from the control value: *, p<0.05; **, p<0.01.
Vol. 30 Special Issue 2.3-6.1 and 11.2-17.9 times in the 60 and 300 ppm groups, respectively, compared to the control group. Effects on MROD, EROD, T-6β-OH, and T4-UDP-GT were also observed, with elevation by 1.5-2.5, 2.7-5.2, 1.7-3.1, and 1.5-3.1 times, respectively, in the 300 ppm group compared to the control group. Data for enzyme activities in males are shown in Fig. 3 .
DISCUSSION
The present two-generation reproduction toxicity study in rats, adding extra endpoints to detect endocrine disrupting activity, demonstrated general toxicological effects on parental animals, influence on reproductive function, and altered development of offspring; however, no distinct changes were evident suggesting endocrine disrupting effects in the extra endpoints such as AGD, nipple development, sexual maturation, estrous cycle, spermatogenesis, sex organ weights, or blood hormone concentrations.
Effects on parental animals
The general toxicological effects, observed in both generations, included suppressed body weight gain and reduced food consumption in both sexes, and deaths in females at 300 ppm. In addition, convulsions and irritability were observed in pregnant F1 females at 300 ppm during the perinatal period. Lindane is known to be neurotoxic, causing irritability, increased activity, and convulsions in rats at repeated high doses Bocklage, 1949, 1950) . Although neurotoxicological manifestations were not seen in F0 animals, lindane is easily transferred to offspring through milk (Shibata, 1978) and immature animals are highly sensitive to toxicity (Doisy and Bocklage, 1949; Srinivasan et al., 1991) . 84.8 ± 21.2 81.9 ± 39.3 67.6 ± 39.5 66.8 ± 19.6 Ambulation 11.9 ± 8.1 13.9 ± 9.5 10.4 ± 8.0 11.3 ± 4.6 Rearing 0.9 ± 1.0 1.2 ± 1.5 0.6 ± 0.8 0.9 ± 1.2 Grooming 0.1 ± 0.3 0.2 ± 0.6 0.1 ± 0. Pathological examination revealed centrilobular hepatocellular hypertrophy in males and females at 10 or 60 ppm and aove, and an increase in hyaline droplets in the proximal tubule epithelium and basophilic renal tubules in males at 10 ppm and above, accompanied by increases in organ weights in F0 and F1 animals. Pulmonary congestion and edema were commonly seen in F0 and F1 females that died at 300 ppm, and appeared to be related to the deaths. Centrilobular hepatocellular hypertrophy is an adaptation in living organisms that occurs when induction of drug metabolizing enzymes is initiated by administration of various drugs 5.2 ± 2.70 4.7 ± 2.06 5.6 ± 2.07 5.4 ± 2.55 UR 1.4 ± 2.37 0.0 ± 0.00 0.1 ± 0.32 0.6 ± 1.58 NO 7.3 ± 2.31 6.6 ± 2.41 6.2 ± 2.86 4.9 ± 3.60 CR 3rd day 2.6 ± 2.07 3.4 ± 2.41 3.8 ± 2.86 4.9 ± 3.60 UR 0.1 ± 0.32 0.0 ± 0.00 0.0 ± 0.00 0.2 ± 0.63 NO 7.3 ± 2.83 6.9 ± 2.42 6.5 ± 1.84 6.1 ± 3.48 CR 4th day 2.7 ± 2.83 3.1 ± 2.42 3.5 ± 1.84 3.9 ± 3.48 UR 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 NO 7.7 ± 2.31 7.9 ± 1.97 7.9 ± 1.97 6.7 ± 3.59 CR 5th day 2.3 ± 2.31 2.1 ± 1.97 2.1 ± 1.97 3.3 ± 3.59 UR 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 NO Females 10 10 10 10 No. of animals examined 4.4 ± 2.07 3.6 ± 2.01 4.9 ± 2.23 2.7 ± 1.83 CR 1st day 2.4 ± 2.01 3.5 ± 1.96 3.4 ± 2.55 4.8 ± 2.15 UR 3.2 ± 2.78 2.9 ± 2.08 1.7 ± 1.06 2.5 ± 2.88 NO 6.0 ± 2.58 6.2 ± 2.90 6.3 ± 2.95 4.5 ± 2.99 CR 2nd day 2.7 ± 1.89 3.8 ± 2.90 3.6 ± 2.95 5.0 ± 2.94 UR 1.3 ± 3.09 0.0 ± 0.00 0.1 ± 0.32 0.5 ± 1.58 NO 8.1 ± 2.92 7.7 ± 3.13 8.7 ± 1.57 6.4 ± 3.41 CR 3rd day 0.9 ± 0.74 2.3 ± 3.13 1.3 ± 1.57 3.6 ± 3.41 UR 1.0 ± 3.16 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 NO 8.0 ± 2.79 7.7 ± 3.13 9.2 ± 0.92 7.7 ± 2.16 CR 4th day 1.1 ± 1.37 2.3 ± 3.13 0.8 ± 0.92 2.3 ± 2.16 UR 0.9 ± 2.85 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 NO 8.2 ± 2.97 8.3 ± 1.83 9.5 ± 0.71 7.7 ± 2.63 CR 5th day 0.8 ± 0.79 1.7 ± 1.83 0.5 ± 0.71 2.3 ± 2.63 UR 1.0 ± 3.16 0.0 ± 0.00 0.0 ± 0.00 0.0 ± 0.00 NO a : Mean ± SD. CR: Conditioned avoidance response. UR: Unconditioned avoidance response. NO: No avoidance response. Significantly different from the control value: *, p<0.05; **, p<0.01.
Fig. 3.
Vol. 30 Special Issue (Gopinath et al., 1987; Greaves, 1990a) . It is thus assumed that this change was related to increases observed in various metabolizing enzyme activities in this study. Increases were in the order (BROD >> EROD > MROD, T-6β-OH, T4-UDP-GT). MROD, EROD, and BROD activities are reported as being highly specific to CYP1A1, CYP1A2, and CYP2B of P450 (Nerurkar et al., 1993) , respectively, while T-6β-OH activity is a highly specific to CYP3A (Arlotto et al., 1991) . This suggests that while lindane most strongly induces CYP2B, it also induces a number of drug metabolizing enzymes, such as CYP1A, CYP3A, and UDP-GT. The appearance of hyaline droplets in the proximal tubule epithelium of the kidney in male rats is related to aging but can be augmented by administration of various drugs (Lehman-McKeeman et al., 1990; Swenberg et al., 1989) . If the occurrence of hyaline droplets is severe, damage occurs in the renal tubule epithelial cells, after which regenerative basophilic renal tubules are observed. Furthermore, since α 2U globulin has been identified in hyaline droplets, these series of changes are referred to as α 2U globulin nephropathy, which is peculiar to male rats (Greaves, 1990b) . Hyaline droplets were observed only in males in this study, which showed a positive reaction to anti-α 2U globulin antibodies, thereby suggesting the presence of α 2U globulin nephropathy.
In the endocrine organs, there was a decrease in the weights of the pituitaries in F0 females and in F1 males and females, and an increase in the weight of the adrenals in F1 males and females at 300 ppm. However, no histological changes were seen; nor were any changes indicating endocrine disruption observed in relation to these changes. Hypertrophy of the thyroid follicular epithelium was observed in F0 females at 300 ppm and in F1 males at 60 and 300 ppm. In addition, blood hormone analysis revealed decreases in T3 and/or T4 in F0 and F1 males and females at 300 ppm. Hypertrophy of the thyroid follicular epithelium occurs as the direct effect of a drug or as a secondary effect through the induction of thyroid hormone-metabolizing enzymes in the liver (Greaves, 1990c) . Measurement of hepatic drug-metabolizing enzyme activities in this study revealed an increase in the activity of T4-UDP-GT, a thyroid hormone-metabolizing enzyme. Therefore, the histological changes in the thyroid and the decrease in T3 and T4 in the blood are presumed to be secondary to enhanced degradation of thyroid hormones in the liver (Owen et al., 1971; Oppenheimer et al., 1968) . Concentrations of sex hormones in blood and the number of ovarian follicles were unaffected by lindane.
Effects on reproductive function
Abnormalities in nursing behavior in F1 dams at 300 ppm, including lack of nursing or pup retrieving behavior, and consequent total litter loss were prominent in the present study. Since F1 dams showed convulsions and irritability, influence of lindane on the nervous system was likely to be responsible. There were no effects of lindane on the estrous cycle, spermatogenesis, mating, fertility, pregnancy, or parturition. There are reports of testicular dysfunction and decrease in sperm counts (Dalsenter et al., 1996) and prolongation of the estrous cycle and delay in vaginal opening (Uphouse and Williams, 1989; Chadwick et al., 1988; Cooper et al., 1989) on administration of lindane to male and female rats, along with testicular dysfunction and decrease in the sperm counts in the succeeding generation of male rats on administration to lactating dams (Dalsenter et al., 1997) . However, such changes were not noted in this study. In the different research reports, the animal strain, doses, administration route, and treatment period varied; therefore, the disparities with the results in this study may have been due to the differences in the study conditions.
Effects on offspring
Suppressed weight gain was observed at 60 and 300 ppm, and decreases in the weights of the thymus and spleen at 300 ppm in both sexes of F1 and F2 offspring. Moreover, there was a decrease in the postnatal survival rate of F2 offspring due to nursing abnormalities in dams at 300 ppm. Post-weaning examination of F1 offspring revealed a delay in sexual maturation (preputial separation and vaginal opening) in both males and females at 300 ppm. Thymus and spleen weights recovered in adult F1 animals with no histopathological changes. When changes in sexual maturation are due to endocrine disrupting activity, they generally occur in either males or females; however, in our study, both males and females were equally affected. Therefore, reduced thymus and spleen weights and delay in sexual maturation were considered as changes associated with developmental delay. Based on reports of the effects of lindane on behavior, including increased activity and learning deficiency (Desi, 1974; Tilson et al., 1987; Rivera et al., 1998) , emotionality, motor coordination, as well as learning and memory were here examined in F1 animals, but no obvious changes were apparent. In the open field test, tenden-cies for decrease in latency time and increase in ambulation were observed in both sexes in the treated groups. However, no significant differences were identified compared to the controls, and it was unclear as to whether these changes were due to the effects of lindane. Discrepancies with previous findings could again be explained by differences in protocols. There were no changes in AGD or nipple development in either males or females.
Assessment of the test method
The results of administering lindane over two generations did not reveal any obvious changes in the extra endpoints for endocrine disrupting activity in any generation even at doses that manifest severe toxicity, including death, despite reports of estrogenic (Raizada et al., 1980) or antiestrogenic (Uphouse and Williams, 1989; Chadwick et al., 1988; Cooper et al., 1989) effects. In uterotrophic and Hershberger assays of lindane conducted in projects of the Ministry of the Environment, no estrogenic or antiestrogenic effects were detected; nor were any androgenic or antiandrogenic effects observed (data not shown). From these results, since any endocrine disrupting activity of lindane is clearly weak, adverse effects might not have been expected in this study. A large number of investigations have shown effects of endocrine disruptors detected by examining AGD, nipple development, sexual maturation, estrous cycle, spermatogenesis, and sex organ weights (Aoyama and Suzuki, 2003; You et al., 2002; Ashby et al., 1997; Sharpe et al., 1995; Newbold et al., 1983; Yamasaki et al., 2005; Chamness et al., 1979; Clevenger et al., 1998; Gray et al., 1993 Gray et al., , 1994 Goldman et al., 1976; Rhees et al., 1997) . Therefore, further studies using other chemicals, which have more definite endocrine disrupting activity, are considered necessary to establish the validity of the new protocol. In a three-generation reproduction study of lindane conducted in the 1970's (Palmer et al., 1978) , in which a maximum dose of 100 ppm was used, it was reported that there were no effects on the next generation or reproductive function. However, lindane did influence development and reproductive function of the succeeding generation in the present study with administration at 300 ppm. This suggests that reproductive and developmental toxicity can be reliably detected by establishing appropriate doses for two-generation reproduction toxicity studies.
